江苏华盛锂电材料股份有限公司 董事会 2025 年 4 月 25 日 江苏华盛锂电材料股份有限公司董事会 关于 2024 年度独立董事独立性自查情况的专项报告 根据《上市公司独立董事管理办法》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等要求， 江苏华盛锂电材料股份有限公司（以下简称"公司"）董事会就公司在任独立董 事黄雄、胡博、温美琴的独立性情况进行评估并出具如下专项意见： 经核查公司独立董事黄雄、胡博、温美琴的任职经历以及签署的相关自查文 件，上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股东单 位担任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进 行独立客观判断的关系。因此，公司董事会认为，公司独立董事符合《上市公司 独立董事管理办法》、《上海证券交易所科创板股票上市规则》、《上海证券交易所 科创板上市公司自律监管指引第 1 号——规范运作》中对独立董事独立性的相关 要求。 ...

容诚会计师事务所（特殊普通合伙）由原华普天健会计师事务所（特殊普通 合伙）更名而来，初始成立于 1988 年 8 月，2013 年 12 月 10 日改制为特殊普通 合伙企业，是国内最早获准从事证券服务业务的会计师事务所之一，长期从事证 券服务业务。注册地址为北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26，首席合伙人刘维。 （二）聘任会计师事务所履行的程序 公司于 2024 年 4 月 23 日召开第二届董事会审计委员会第八次会议，审议通 过了《关于续聘会计师事务所的议案》，并同意将该议案提交董事会审议。公司 随即召开第二届董事会第十二次会议，审议并全票通过了《关于续聘会计师事务 所的议案》，同意继续聘任容诚会计师事务所为公司 2024 年度审计机构，后该议 案于 2024 年 5 月 15 日经 2023 年年度股东大会审议通过。 二、会计师事务所履职情况 江苏华盛锂电材料股份有限公司董事会审计委员会 对会计师事务所 2024 年度履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《国有企业、上市公司选聘会计师事务所管理办 ...

证券代码：688353 证券简称：华盛锂电 公告编号：2025-023 江苏华盛锂电材料股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 拟聘任的会计师事务所名称：容诚会计师事务所（特殊普通合伙） 一、拟聘任会计师事务所的基本情况 （一）机构信息 1、基本信息 容诚会计师事务所（特殊普通合伙）由原华普天健会计师事务所（特殊普通 合伙）更名而来，初始成立于 1988 年 8 月，2013 年 12 月 10 日改制为特殊普通 合伙企业，是国内最早获准从事证券服务业务的会计师事务所之一，长期从事证 券服务业务。注册地址为北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26，首席合伙人刘维。 2、人员信息 截至 2024 年 12 月 31 日，容诚会计师事务所共有合伙人 212 人，共有注册 会计师 1552 人，其中 781 人签署过证券服务业务审计报告。 3、业务规模 4、投资者保护能力 容诚会计师事务所已购买注册会计师职业责任保险， ...

证券代码：688353 证券简称：华盛锂电 公告编号：2025-027 江苏华盛锂电材料股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024年年度股东大会 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票 相结合的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 5 月 15 日 13 点 30 分 召开地点：江苏扬子江国际化学工业园德盛路 1 号公司一楼会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 股东大会召开日期：2025年5月15日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 网络投票起止时间：自2025 年 5 月 15 日 至2025 年 5 月 15 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当 ...

证券代码：688353 证券简称：华盛锂电 公告编号：2025-020 江苏华盛锂电材料股份有限公司 第二届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 江苏华盛锂电材料股份有限公司（以下简称"公司"）第二届监事会第十七次 会议于 2025 年 4 月 23 日以现场与通讯相结合的方式召开。公司于 2025 年 4 月 13 日以邮件等方式向全体监事发出召开本次会议的通知，与会的各位监事已知 悉与所议事项相关的必要信息。本次会议由监事会主席周超主持，会议应到监事 3 名，实到监事 3 名，会议的召集和召开程序符合《中华人民共和国公司法》（以 下简称"《公司法》"）等法律、法规、部门规章以及《江苏华盛锂电材料股份有 限公司章程》（以下简称"《公司章程》"）的有关规定，作出的决议合法、有效。 会议以现场与通讯表决方式审议通过了以下议案： 二、监事会会议审议情况 1、审议通过《关于公司<2024 年度监事会工作报告>的议案》 监事会认为：2024 年，公司监事会根据《公司法》 ...

证券代码：688353 证券简称：华盛锂电 公告编号：2025-019 江苏华盛锂电材料股份有限公司 第二届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏华盛锂电材料股份有限公司（以下简称"公司"）第二届董事会第二十一 次会议于 2025 年 4 月 23 日以现场与通讯相结合的方式召开。公司于 2025 年 4 月 13 日以邮件等方式向全体董事发出召开本次会议的通知，与会的各位董事已 知悉与所议事项相关的必要信息。本次会议由董事长沈锦良先生召集并主持，会 议应到董事 9 名，实到董事 9 名，会议的召集和召开程序符合《中华人民共和国 公司法》（以下简称"《公司法》"）等法律、法规、部门规章以及《江苏华盛锂 电材料股份有限公司章程》（以下简称"《公司章程》"）的有关规定，作出的决 议合法、有效。会议以现场与通讯表决方式审议通过了以下议案： 1、审议通过《关于公司<2024 年度总经理工作报告>的议案》 2、审议通过《关于公司<2024 年度董事会工作报告>的议案》 董事会审议通过了《江 ...

证券代码：688353 证券简称：华盛锂电 公告编号：2024-021 江苏华盛锂电材料股份有限公司 关于公司 2024 年度利润分配方案公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 江苏华盛锂电材料股份有限公司（以下简称"公司"）2024 年度不派发 现金红利，不进行公积金转增股本，不送股。 公司 2024 年度归属于母公司所有者的净利润为负，综合考虑公司盈利 状况、发展战略、发展规划及资金需求，为保障公司持续、稳定、健康发展，更 好地维护全体股东的长远利益，经公司审慎研究讨论，拟定 2024 年度不派发现 金红利，不进行公积金转增股本，不送股。 公司 2024 年年度利润分配预案已经公司第二届董事会第二十一次会 议、第二届监事会第十七次会议审议通过，尚需提交公司 2024 年年度股东大会 审议。 本次利润分配方案不会触及《上海证券交易所科创板股票上市规则 （2024 年 4 月修订）》（以下简称《科创板股票上市规则》）第 12.9.1 条第一 款第（八）项规定的可能被实施其他风险警示的情形。 一 ...

Financial Performance - The net profit attributable to shareholders for 2024 was -174.6748 million RMB, with accumulated undistributed profits as of December 31, 2024, amounting to 368.7084 million RMB[6]. - The total cash dividend for the first three quarters of 2024 was 47.3125 million RMB, with a share repurchase amount of 40.3090 million RMB, leading to a combined total of 87.6215 million RMB[7]. - The company will not distribute cash dividends, issue bonus shares, or increase capital reserves due to the negative net profit for the year[6]. - The company's operating revenue for 2024 is CNY 504,899,353.12, a decrease of 3.83% compared to CNY 525,031,402.36 in 2023[23]. - The net profit attributable to shareholders for 2024 is CNY -174,674,817.37, compared to CNY -23,911,803.46 in 2023[23]. - The net cash flow from operating activities for 2024 is CNY -110,656,959.03, an improvement from CNY -134,894,897.67 in 2023[23]. - The company reported a significant decrease in net profit, indicating challenges in the current market environment[23]. - The net profit attributable to shareholders decreased by 7% to approximately CNY 3.47 billion compared to the previous year[24]. - Basic earnings per share dropped significantly to -CNY 1.10, down from -CNY 0.15 in the previous year[24]. - The weighted average return on equity fell to -4.82%, a decrease of 4.19 percentage points from the previous year[24]. - The overall revenue of listed companies in the lithium battery supply chain is estimated to decline by 20.21% year-on-year in the first half of 2024, with a gross margin of 18.94%, down 2.26 percentage points[70]. - The company's overall gross margin for the reporting period was -19.41%, a significant decline from 11.28% in the previous year, primarily due to excess supply and price drops in the industry[124]. Production and Capacity Expansion - The company plans to expand its production capacity with projects including a 20,000-ton low-energy high-performance lithium battery anode material project[1]. - The first phase of the lithium difluoro(oxalato)borate project will have an annual production capacity of 500 tons[1]. - The company aims to achieve a production capacity of 6,000 tons of vinyl carbonate and 3,000 tons of fluorinated carbonic acid ethyl ester[1]. - The company has successfully completed the technical transformation of a project with an annual production capacity of 6,000 tons of vinyl carbonate and 3,000 tons of fluorinated ethylene carbonate, enhancing production efficiency[43]. - The company is actively expanding its production capacity for electrolyte additives, with a current annual production capacity of 14,000 tons for VC and FEC products[47]. - The company has established a new production line with an annual capacity of 500 tons for lithium difluoro(oxalato)borate and 2000 tons for MMDS[83]. Research and Development - The company is actively engaging in research and development to improve its product offerings and maintain competitiveness[1]. - The company is focusing on the research and development of lithium battery-related materials, including low-energy, high-performance graphite anodes and sodium-ion batteries[35]. - The company aims to strengthen its core competitiveness by exploring cutting-edge technologies for next-generation battery additives and electrolytes[35]. - The company has authorized a total of 135 patents, including 85 invention patents and 48 utility model patents, demonstrating a strong commitment to R&D and innovation[38]. - The R&D team consists of 119 members, accounting for 10.62% of the total workforce, ensuring the company's strong research capabilities and stability in core technical personnel[82]. - The company holds multiple core technologies in lithium battery electrolyte additives and special organic silicon, with a focus on continuous innovation and self-research[82]. - The company has established four provincial-level research stations and a national postdoctoral workstation, further strengthening its R&D capabilities[38]. - The company has made significant investments in R&D, reflecting its commitment to innovation and product development[101]. - Total R&D expenses decreased by 13.56% from the previous year, amounting to ¥41,023,937.27, with the ratio of R&D expenses to operating income dropping from 9.04% to 8.13%[102]. Market and Sales - The company is focusing on market expansion and technological advancements in the lithium battery materials sector[1]. - The company’s products, including VC and FEC, are primarily supplied to new energy vehicle manufacturers, reflecting a strong market demand in this sector[63]. - The company’s sales model includes direct sales and distribution, with major clients in the lithium battery supply chain, including BYD and Mitsubishi Chemical[63]. - The company plans to continue expanding its market presence, particularly in overseas markets, leveraging its established brand reputation and customer resources[72]. - In 2024, global sales of new energy vehicles are expected to reach 18.236 million units, a year-on-year increase of 24.4%, with China's sales projected at 12.866 million units, up 35.5%[67]. - The demand for lithium battery electrolyte additives is anticipated to rise significantly, benefiting from the continuous expansion of the lithium battery industry and increasing requirements for safety, cycle life, and charge/discharge speed[68]. - The company’s main business revenue from lithium battery electrolyte additives decreased by 3.87% to CNY 504.67 million, primarily due to intense market competition and a significant drop in product sales prices[135]. - Domestic sales revenue fell by 22.69% to CNY 445.41 million, while export sales increased by 5.02% to CNY 59.26 million[138]. Risks and Challenges - The company faces risks from potential changes in environmental protection regulations, which could lead to production limitations or increased operational costs[121]. - The company is at risk of being replaced by competitors if it fails to keep up with new electrolyte formulations and performance requirements in the lithium battery market[122]. - The company’s export business is a significant revenue source, and fluctuations in the RMB exchange rate could adversely impact profits[123]. - The company is exposed to risks from the loss of core technical personnel, which could hinder its innovation and operational capabilities[119]. - The company must navigate the risk of technological obsolescence in the lithium battery sector, as new technologies may surpass current lithium-ion battery performance[116]. - The company faces risks related to macroeconomic conditions, industry competition, and potential project delays or cancellations[130][132]. Innovations and New Technologies - The company has developed a new industrial production process for LiFSI, achieving a production capacity of 1,000,000 units, with a current output of RMB 745.44 million[106]. - The production process for ethylene carbonate was improved, resulting in a synthesis yield increase and a reduction in solvent usage, with a production capacity of 1,250,000 units and an output of RMB 1,388.89 million[106]. - The company developed a continuous flow reaction technology for vinyl carbonate (VC), increasing reaction efficiency and reducing process time by over 50% while lowering material consumption by 10%[86]. - The company’s fluorinated carbonate ester (FEC) production process has a high conversion rate and low by-product generation, with the product receiving multiple national and international patents[88]. - The company has developed LiBOB, an electrolyte additive that enhances the cycling performance of lithium batteries by forming a stable protective film on the surface of cathode materials, with ongoing improvements in production processes to reduce costs[90]. - The company is advancing the industrialization of silicon-carbon anode materials, which address the challenges of volume expansion and short cycle life associated with pure silicon anodes[94]. - The innovative HSI003 cathode film-forming additive is in the critical market promotion phase, showing superior performance in high-rate cycling and high-temperature storage compared to benchmark formulations[81]. Environmental and Compliance - The company has established a complete waste treatment system, including bioreactors and incinerators, to ensure compliance with environmental regulations[112]. - The production yield for a new type of isocyanate-based silane reached over 90%, showcasing the company's commitment to green production methods[110].

Financial Performance - The company's operating revenue for Q1 2025 was ¥166,142,190.23, representing a 62.64% increase compared to ¥102,154,768.57 in the same period last year[4] - The net profit attributable to shareholders was -¥43,082,807.88, a significant decline from -¥12,803,257.91 year-on-year[4] - The net cash flow from operating activities was -¥80,878,582.34, worsening from -¥34,072,927.43 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥166,142,190.23, a significant increase of 62.7% compared to ¥102,154,768.57 in Q1 2024[20] - Net loss for Q1 2025 amounted to ¥46,341,786.50, compared to a net loss of ¥15,350,980.12 in Q1 2024, reflecting a deterioration in profitability[22] - The company's basic and diluted earnings per share for Q1 2025 were both -¥0.27, compared to -¥0.08 in Q1 2024[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,225,875,459.29, a decrease of 1.50% from ¥4,290,085,764.97 at the end of the previous year[5] - As of March 31, 2025, the total current assets amounted to ¥2,082,867,300.93, a decrease from ¥2,202,492,578.67 as of December 31, 2024, reflecting a decline of approximately 5.4%[14] - The company's cash and cash equivalents decreased to ¥515,466,870.21 from ¥782,151,750.23, representing a significant drop of about 34.1%[14] - The accounts receivable increased to ¥333,039,237.25 from ¥296,284,219.59, indicating a growth of approximately 12.4%[14] - The total non-current assets increased to ¥2,143,008,158.36 from ¥2,087,593,186.30, showing an increase of about 2.7%[15] - The total liabilities included accounts payable of ¥167,202,945.43, down from ¥265,695,457.80, indicating a decrease of approximately 37.1%[15] - Total liabilities increased to ¥733,295,506.07 in the latest reporting period, compared to ¥723,589,261.59 previously[17] - Non-current liabilities rose to ¥307,304,617.36, up from ¥223,431,012.10, indicating increased long-term financial obligations[17] - The company's total equity decreased to ¥3,492,579,953.22 from ¥3,566,496,503.38, reflecting a decline in shareholder value[17] Research and Development - Research and development expenses totaled ¥10,199,146.92, which is a 20.89% increase from ¥8,436,693.76 in the same period last year[5] - Research and development expenses for Q1 2025 were ¥10,199,146.92, an increase from ¥8,436,693.76 in Q1 2024, highlighting ongoing investment in innovation[21] Cash Flow - The net cash flow from operating activities was -80,878,582.34, compared to -34,072,927.43 in the previous period, indicating a decline in operational performance[24] - Total cash inflow from investment activities was 895,764,486.49, significantly higher than 55,348.20 in the previous period, reflecting increased investment recovery[24] - Cash outflow from investment activities totaled 1,135,895,154.61, compared to 1,591,113,114.13 previously, showing a reduction in investment spending[25] - The net cash flow from financing activities was 55,880,278.01, a positive shift from -2,733,591.43 in the previous period, indicating improved financing conditions[25] - The ending balance of cash and cash equivalents was 462,411,260.12, down from 356,871,290.76 in the previous period, reflecting liquidity challenges[25] - The company received 889,770,000.00 in cash from investment recoveries, marking a significant inflow compared to previous periods[24] - Cash paid for the purchase of fixed assets and other long-term assets was 138,973,054.61, indicating ongoing capital expenditures[24] - The company reported a total cash inflow from operating activities of 96,314,761.40, down from 118,179,267.31 previously, suggesting a decrease in operational cash generation[24] - The cash received from other operating activities was 2,879,124.88, compared to 2,172,101.20 in the previous period, showing a slight increase[24] - The company experienced a negative impact of 275,825.32 from foreign exchange fluctuations on cash and cash equivalents[25] Shareholder Information - The company had a total of 9,348 common shareholders at the end of the reporting period[9] - The company held a total of 3,387,397 shares in its repurchase account, accounting for 2.12% of the total share capital[11] - The top ten shareholders include significant holdings from various investment partnerships, with the largest being Suzhou Huizhang Investment Partnership holding 6,838,635 shares[11] - The company reported no changes in the participation of the top ten shareholders in securities lending or borrowing activities[12] Sales and Revenue - The increase in operating revenue was attributed to a significant rise in sales volume of main products[8] - Total operating costs for Q1 2025 were ¥211,473,273.49, up 60.9% from ¥131,449,859.87 in Q1 2024[20]

RSM 容 诚 2024 年度营业收入扣除情况的 专项审核报告 江苏华盛锂电材料股份有限公司 容诚专字|2025]230Z1041 号 容诚会计师事务所(特殊普通合伙) 中国 · 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn)"进 报告编码:京25 | 序号 | 内 容 | 页码 | | --- | --- | --- | | I | 营业收入扣除情况的专项审核报告 | 1-2 | | 2 | 营业收入扣除情况表 | 3 | 目 录 关于江苏华盛锂电材料股份有限公司 2024年度营业收入扣除情况的专项审核报告 容诚专字[2025]230Z1041 号 江苏华盛锂电材料股份有限公司全体股东: 我们接受委托,按照中国注册会计师审计准则审计了江苏华盛锂电材料股份 有限公司(以下简称华盛锂电)2024年度财务报表,并于 2025年4月23日出具 了容诚审字[2025]230Z1663 号的无保留意见审计报告。在此基础上我们审核了后 附的华盛锂电管理层编制的《江苏华盛锂电材料股份有限公司 2024 年度营业收入 扣除情况表》（以下简称营业收入扣除情况表）。 ...